Silverarc Capital Management’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Hold |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $2.27M | Sell |
|
|||||
|
2023
Q1 | $1.78M | Sell |
|
|||||
|
2022
Q4 | $5.55M | Sell |
|
|||||
|
2022
Q3 | $8.56M | Buy |
|
|||||
|
2022
Q2 | $7.53M | Buy |
|
|||||
|
2022
Q1 | $4.75K | Sell |
|
|||||
|
2021
Q4 | $4.16M | Buy |
|
|||||
|
2021
Q3 | $3.12M | Sell |
|
|||||
|
2021
Q2 | $3.31K | Sell |
|
|||||
|
2021
Q1 | $8.49M | Buy |
|